X-linked infantile spasms
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
In five subjects, deletions include SPTAN1, previously associated with early infantile epileptic encephalopathy, infantile spasms, intellectual disability, and hypomyelination.
|
22722545 |
2012 |
X-linked infantile spasms
|
0.110 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
West Syndrome
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Progressive diffuse brain atrophy in West syndrome with marked hypomyelination due to SPTAN1 gene mutation.
|
22656320 |
2013 |
West Syndrome
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
By screening SPTAN1 in 95 patients with idiopathic ID, we found a de novo in-frame mutation (p.Q2202del) in the same C-terminal domain in a patient with mild generalized epilepsy and pontocerebellar atrophy, but without IS, hypomyelination, or other brain structural defects, allowing us to define the core phenotype associated with these C-terminal SPTAN1 mutations.
|
22258530 |
2012 |
West Syndrome
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
The major clinical features of SPTAN1 mutations include epileptic encephalopathy with hypsarrhythmia, no visual attention, acquired microcephaly, spastic quadriplegia and severe intellectual disability.
|
25631096 |
2015 |
West Syndrome
|
0.460 |
Biomarker
|
disease |
HPO |
|
|
|
West Syndrome
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
De novo in-frame deletions and duplications in the SPTAN1 gene, encoding the non-erythrocyte αII spectrin, have been associated with severe West syndrome with hypomyelination and pontocerebellar atrophy.
|
29050398 |
2017 |
West Syndrome
|
0.460 |
Biomarker
|
disease |
BEFREE |
Infantile spasms may be associated with interactions between ATXN2 and the postsynaptic structural proteins MAGI2 and SPTAN1.
|
21880993 |
2011 |
West Syndrome
|
0.460 |
GermlineCausalMutation
|
disease |
ORPHANET |
Genes of early-onset epileptic encephalopathies: from genotype to phenotype.
|
22196487 |
2012 |
West Syndrome
|
0.460 |
GermlineCausalMutation
|
disease |
ORPHANET |
Early onset West syndrome with cerebral hypomyelination and reduced cerebral white matter.
|
18065176 |
2008 |
West Syndrome
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay.
|
20493457 |
2010 |
Variable expressivity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Tumor Progression
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
To investigate the link between MLH1 and SPTAN1 in cancer progression, a cohort of 189 patients with CRC was analyzed by immunohistochemistry.
|
30856214 |
2019 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Further, a prophage gene, STM2699, induced in cold-stressed Salmonella and a spectrin gene, SPTAN1, induced in Salmonella-infected intestinal epithelial cells were found to have a significant contribution in increased adhesion and invasion of cold-stressed Salmonella in epithelial cells.
|
25192993 |
2014 |
Tuberculosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
This study suggests the possible role of decreased levels of αII-spectrin in the pathology of tuberculosis.
|
24055022 |
2013 |
Thyroid Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Moreover, both children have abnormal thyroid function, which has not been previously reported in association with SPTAN1 variant.
|
30548380 |
2018 |
Subarachnoid Hemorrhage
|
0.010 |
Biomarker
|
disease |
BEFREE |
Evaluation of alpha-II-spectrin breakdown products as potential biomarkers for early recognition and severity of aneurysmal subarachnoid hemorrhage.
|
30190542 |
2018 |
Stomach Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Alpha-II spectrin, Na/K-ATPase and KIAA0111 are those that are enhanced in intestinal type of gastric cancer.
|
12127692 |
2002 |
Spastic Quadriplegia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sjogren's Syndrome
|
0.030 |
Biomarker
|
disease |
LHGDN |
Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome.
|
16192640 |
2005 |
Sjogren's Syndrome
|
0.030 |
Biomarker
|
disease |
BEFREE |
Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to alpha-fodrin antibodies.
|
16935916 |
2007 |
Sjogren's Syndrome
|
0.030 |
Biomarker
|
disease |
LHGDN |
The role of caspase cascade on the development of primary Sjögren's syndrome.
|
12630566 |
2003 |
Severe intellectual disability
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Severe intellectual disability
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
The major clinical features of SPTAN1 mutations include epileptic encephalopathy with hypsarrhythmia, no visual attention, acquired microcephaly, spastic quadriplegia and severe intellectual disability.
|
25631096 |
2015 |
Seizures
|
0.120 |
GeneticVariation
|
phenotype |
BEFREE |
This report supports the causative relationship between SPTAN1 mutations and early onset intractable seizures with severe hypomyelination and widespread brain volume reduction.
|
22429196 |
2012 |